Latest news & views

This channel includes the latest news, interviews and opinion pieces on regenerative medicine, stem cells, cell and gene therapy, and other advanced therapies from around the world, aiming to keep you up to date with the field and aware of different insights and perspectives.

Member Exclusive

Will Stem Cell Profits Measure Up?

It makes no sense to look at stem cell companies differently from drug or biologics companies. The technology may be different, but the diseases they seek to treat are the same. In fact, cell therapies may ultimately be more useful and more curative than drugs, and hence more valuable. That's the way Alain Vertès of NxR Biotechnologies sees it. In this interview with The Life Sciences Report, Vertès talks about some of the stem cell names he knows well, and draws comparisons investors can bank on.
Go to the profile of Lee Buckler
Mar 19, 2015